| __timestamp | BioCryst Pharmaceuticals, Inc. | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 12404000 |
| Thursday, January 1, 2015 | 72758000 | 18343000 |
| Friday, January 1, 2016 | 61008000 | 18108000 |
| Sunday, January 1, 2017 | 66962000 | 17614000 |
| Monday, January 1, 2018 | 84888000 | 35619000 |
| Tuesday, January 1, 2019 | 107068000 | 58432000 |
| Wednesday, January 1, 2020 | 122964000 | 63945000 |
| Friday, January 1, 2021 | 208808000 | 72200000 |
| Saturday, January 1, 2022 | 253297000 | 76642000 |
| Sunday, January 1, 2023 | 216566000 | 57519000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. BioCryst Pharmaceuticals, Inc. and Evotec SE, two prominent players in the industry, have shown distinct trends in their R&D investments over the past decade.
From 2014 to 2023, BioCryst Pharmaceuticals increased its R&D expenses by over 300%, peaking in 2022. This surge underscores their aggressive pursuit of new treatments and therapies. In contrast, Evotec SE's R&D spending grew by approximately 460% during the same period, reflecting a steady and strategic approach to innovation.
The data reveals that while BioCryst's R&D spending saw a slight dip in 2023, Evotec maintained a consistent investment strategy. These trends highlight the dynamic nature of R&D funding and its critical role in driving pharmaceutical advancements.
Vertex Pharmaceuticals Incorporated vs Evotec SE: Strategic Focus on R&D Spending
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Evotec SE
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Ascendis Pharma A/S vs BioCryst Pharmaceuticals, Inc.
R&D Insights: How Grifols, S.A. and BioCryst Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: MannKind Corporation vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Celldex Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.